Infectious Diseases & Vaccines

Infectious diseases remain a global health challenge, demanding innovative solutions and robust clinical research. At Pivotal, we specialize in the design and execution of Phase 1–4 clinical trials for vaccines and infectious disease therapies, including those targeting antimicrobial resistance (AMR).

Our team brings deep expertise in managing complex, multi-centre trials across diverse populations and geographies. We understand the urgency and intricacies of infectious disease studies and offer flexible, efficient solutions to accelerate development timelines while maintaining the highest standards of quality and patient safety.

From first-in-human vaccine studies to pivotal trials for novel anti-infectives, including AMR-focused therapies, we are committed to supporting your clinical development goals and bringing effective treatments to the patients who need them most.